September 2011. Volume 7. Number 3

Idiopathic short stature and growth hormone: several doubts and some recommendations

 
 
 
 
 
 
 
 
 
 
Rating: 5 (1 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

ED | Editorial

Author: López Siguero JP1.
1Unidad de Endocrinología Pediátrica. Hospital Materno-Infantil. Hospital Regional Universitario Carlos Haya. Málaga. España.
Correspondence: Juan Pedro López Siguero. Email: lopez.siguero@gmail.com
Publication date: 24/08/2011

How to cite this article

López Siguero JP. Talla baja idiopática y hormona de crecimiento: bastantes dudas y algunas recomendaciones. Evid Pediatr. 2011;7:51.

ED | Editorial

Author: López Siguero JP1.
1Unidad de Endocrinología Pediátrica. Hospital Materno-Infantil. Hospital Regional Universitario Carlos Haya. Málaga. España.
Correspondence: Juan Pedro López Siguero. Email: lopez.siguero@gmail.com
Publication date: 24/08/2011

How to cite this article

López Siguero JP. Talla baja idiopática y hormona de crecimiento: bastantes dudas y algunas recomendaciones. Evid Pediatr. 2011;7:51.

References

  1. Rosenbloom AL. Pediatric endo-cosmetology and the evolution of growth diagnosis and treatment. J Pediatr. 2011;158:187-93.
  2. Cohen P, Rogol AD, Deal CL, Sanger P, Reiter EO, Ross JL et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocr Metab. 2008;93:4210-7.
  3. Carrascosa A, Ferrández-Longás A, Gracia R, López-Siguero JP, Pombo M, Yturriaga R. Talla baja idiopática. Revisión y puesta al día. An Pediatr (Barc). 2011. doi:10.1016/j.anpedi. 2011.05.007.
  4. Savage MO, Burrent CP, Rosenfeld RG. The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges. Clin Endocrinol. 2010;72:721-8.
  5. Carrascosa A, Audi L, Fernández-Cancio M, Yeste D, Gussinye M, Albisu MA et al. Growth hormone secretory status evaluated by growth hormone peak after two pharmacological GH release stimuli did not significantly influence the two-year catch-up growth induced by Gh therapy in 318 prepubertal short children with idiopathic growth retardation. Horm Res Paediatric. 2011;75:106-14.
  6. Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G. Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatr. 2007;96:715-9.
  7. Human growth hormone (somatotropin) for the treatment of growth failure in children. [En línea] [fecha de consulta: 27-VII-2011. Disponible en: http://www.nice.org.uk/guidance/TA188
  8. Deodati A, Cianfarani S. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review. BMJ. 2011;342:c7157.
  9. González de Dios J, González Rodríguez P. Niños con talla baja idiopática y tratamiento con hormona del crecimiento: situación actual. Evid Pediatr. 2011;7:55.
  10. Safety and appropriateness of growth hormone treatments in Europe. [En línea] [fecha de consulta: 27 - VII - 2011]. Disponible en: http://saghe.aphp.fr/site

Related Articles

AVC | Chidren with idiopatic short stature and therapy with growth hormone: current situation

González de Dios J, González Rodríguez MP. Niños con talla baja idiopática y tratamiento con hormona de crecimiento: situación actual. Evid Pediatr. 2011;7:55.
24/08/2011

Linked Comment